Research output per year
Research output per year
Search results
-
2016
Validation of SCT methylation as a hallmark biomarker for lung cancers
Zhang, Y. A., Ma, X., Sathe, A., Fujimoto, J., Wistuba, I. I., Lam, S., Yatabe, Y., Wang, Y. W., Stastny, V., Gao, B., Larsen, J. E., Girard, L., Liu, X., Song, K., Behrens, C., Kalhor, N., Xie, Y., Zhang, M. Q., Minna, J. D. & Gazdar, A. F., Mar 23 2016, In: Journal of Thoracic Oncology. 11, 3, p. 346-360 15 p.Research output: Contribution to journal › Article › peer-review
Open Access11 Scopus citations -
2014
A reevaluation of CD22 expression in human lung cancer
Pop, L. M., Barman, S., Shao, C., Poe, J. C., Venturi, G. M., Shelton, J. M., Pop, I. V., Gerber, D. E., Girard, L., Liu, X. Y., Behrens, C., Rodriguez-Canales, J., Liu, H., Wistuba, I. I., Richardson, J. A., Minna, J. D., Tedder, T. F. & Vitetta, E. S., Jan 1 2014, In: Cancer research. 74, 1, p. 263-271 9 p.Research output: Contribution to journal › Article › peer-review
Open Access16 Scopus citations -
2012
Immunotoxins constructed with chimeric, short-lived anti-CD22 monoclonal antibodies induce less vascular leak without loss of cytotoxicity
Liu, X. Y., Pop, L. M., Schindler, J. & Vitetta, E. S., Jan 2012, In: mAbs. 4, 1, p. 57-68 12 p.Research output: Contribution to journal › Article › peer-review
20 Scopus citations -
2011
A comparison of the anti-tumor effects of a chimeric Versus murine anti-CD19 immunotoxins on human B cell lymphoma and pre-B acute lymphoblastic leukemia cell lines
Tsai, L. K., Pop, L. M., Liu, X. & Vitetta, E. S., Apr 2011, In: Toxins. 3, 4, p. 409-419 11 p.Research output: Contribution to journal › Article › peer-review
3 Scopus citations -
Chimeric, divalent and tetravalent anti-CD19 monoclonal antibodies with potent in vitro and in vivo antitumor activity against human B-cell lymphoma and pre-B acute lymphoblastic leukemia cell lines
Liu, X. Y., Pop, L. M., Tsai, L., Pop, I. V. & Vitetta, E. S., Jul 15 2011, In: International Journal of Cancer. 129, 2, p. 497-506 10 p.Research output: Contribution to journal › Article › peer-review
10 Scopus citations -
2008
Engineering therapeutic monoclonal antibodies
Liu, X. Y., Pop, L. M. & Vitetta, E. S., Apr 2008, In: Immunological Reviews. 222, 1, p. 9-27 19 p.Research output: Contribution to journal › Review article › peer-review
88 Scopus citations -
2006
Generation and characterization of a novel tetravalent anti-CD22 antibody with improved antitumor activity and pharmacokinetics
Liu, X. Y., Pop, L. M., Roopenian, D. C., Ghetie, V., Vitetta, E. S. & Smallshaw, J. E., May 2006, In: International Immunopharmacology. 6, 5, p. 791-799 9 p.Research output: Contribution to journal › Article › peer-review
11 Scopus citations -
2005
The generation of immunotoxins using chimeric anti-CD22 antibodies containing mutations which alter their serum half-life
Pop, L. M., Liu, X., Ghetie, V. & Vitetta, E. S., Jul 1 2005, In: International Immunopharmacology. 5, 7-8, p. 1279-1290 12 p.Research output: Contribution to journal › Article › peer-review
15 Scopus citations -
2004
The Evaluation of Recombinant, Chimeric, Tetravalent Antihuman CD22 Antibodies
Meng, R., Smallshaw, J. E., Pop, L. M., Yen, M., Liu, X., Le, L., Ghetie, M. A., Vitetta, E. S. & Ghetie, V., Feb 15 2004, In: Clinical Cancer Research. 10, 4, p. 1274-1281 8 p.Research output: Contribution to journal › Article › peer-review
20 Scopus citations